Skip to main content

What are you looking for?

Write the name, title or any keyword related to what you are looking for and select which content category it belongs to.

Year
2024
Data d'inici
Data de tancament
Descripció
Clinical researcher-Headache and Neurological Pain Research Group_20240306
Codi
2024-306
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Graduate technician Pneumology Group-Pneumology Research Group_20240307
Codi
2024-307
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
HR Project Manager_20240304
Codi
2024-304
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Support Technician Veterinary_20240305
Codi
2024-305
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Laboratory technician-Nephrology and Transplantation Research Group_20240302
Codi
2024-302
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Research Assistant-Group of Research of Allergology and Immunology Laboratory. Systemic Diseases Research Group_20240303
Codi
2024-303
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Study coordinator / Data manager-Infectious Diseases Group_20240301
Codi
2024-301
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Research Technician_Biomedical Research in Cancer Stem Cells_20240300
Codi
2024-300
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Accountant Officer_20240299
Codi
2024-299
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Biobank Technician_20240298
Codi
2024-298
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Software Technician_20240297
Codi
2024-297
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Head of Software Development and System & Data architecture_20240296
Codi
2024-296
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Descripció
Data Manager Septic and Reconstructive Surgery Unit_20240294
Codi
2024-294
Reclutant
Inactiu
Year
2024
Data d'inici
Data de tancament
Grup de recerca
Descripció
Graduate Technician Diabetes and Metabolism Department
Codi
2024-295
Reclutant
Inactiu

Estudio fase II de Avelumab más quimioterapia en el tratamiento perioperatorio de pacientes con carcinoma gástrico (CG) o de la unión gastroesofágica (CUGE) localmente avanzado resecable. Estudio MONEO

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

  • Protocol code: ITL-2001-CL-301
  • EudraCT code: No aplica
  • Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
  • Principal investigator:  Martínez Valle, Fernando
  • Research group:  Systemic Diseases
  • Service: Medicina Interna
  • Phase: Fase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Tranexamic acid for hyperacute spontaneous IntraCerebral Haemorrhage (TICH-3).

  • Protocol code: 21022 (TICH-3)
  • EudraCT code: 2021-001050-62
  • Pathology: Malalties del sistema nerviós
  • Principal investigator:  Rodriguez Luna, David
  • Research group:  Recerca en ictus
  • Service: Neurologia
  • Phase: Phase III
  • Recruiting: Open
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Ensayo de fase III multicéntrico, aleatorizado, doble ciego, comparativo con placebo, de 48 semanas de duración, para evaluar la eficacia y la seguridad de survodutide administrada por vía subcutánea en participantes con sobrepeso u obesidad y esteatohepatitis no alcohólica (EHNA) presunta o confirmada.

  • Protocol code: 1404-0056
  • EudraCT code: No aplica
  • Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified
  • Principal investigator:  Pericàs Pulido, Juan Manuel
  • Research group:  Malalties hepàtiques
  • Service: Hepatologia
  • Phase: Phase III
  • Recruiting: Closed
  • Status: Open

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Un estudio de fase IIb, multicéntrico, aleatorizado, doble ciego, de búsqueda de dosis, para evaluar la eficacia, seguridad y tolerabilidad de balcinrenona en combinación con dapagliflozina en comparación con dapagliflozina en pacientes con enfermedad renal crónica y albuminuria.

  • Protocol code: D6405C00002
  • EudraCT code: No aplica
  • Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified
  • Principal investigator:  Soler Romeo, Maria Jose
  • Research group:  Nephrology and kidney transplantation
  • Service: Nefrologia
  • Phase: Phase II
  • Recruiting: Open
  • Status: Tancat

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.

Estudio de fase 1/3, doble ciego, aleatorizado, con control activo yde grupos paralelos para comparar la eficacia, la farmacocinética, la farmacodinámicay la seguridad de CT-P53 y Ocrevus en pacientes con esclerosis múltiple remitenterecurrente

Contact Form

I have read and accept the data protection policy *.

Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.
Purpose: Request for information on VHIR clinical research.
Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.
Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.
Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.
Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information 
The request for information on a research project or clinical trial does not entail inclusion in it.